Greenstone Biosciences is classified as operating in the Research & Development in the Physical, Engineering & Life Sciences industry, NAICS Code 54171.
Investor Activity
Greenstone Biosciences has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
May 4, 2022
20
91%
$11 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Greenstone Biosciences is developing and marketing.
Greenstone Biosciences doesn't have any recent trademark applications, indicating Greenstone Biosciences is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
GREENSTONE BIOSCIENCES Research and development in the pharmaceutical and biotechnology fields
05/03/2022
See all trademarks and details in the Full Report.
Market Share of Greenstone Biosciences's Largest Competitors
A competitive analysis shows these companies are in the same general field as Greenstone Biosciences, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Greenstone Biosciences.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Greenstone Biosciences and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.